시장보고서
상품코드
1148970

세계의 유도만능줄기세포(iPS 세포) 시장 : 기회와 전략(-2031년)

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2031

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 276 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 유도만능줄기세포(iPS 세포) 시장에 대해 조사했으며, 파생 세포 유형·용도·최종사용자별 세분화, 주요 시장 동향, 시장 규모와 성장, 지역/국가별 분석, 기업 개요 등에 관한 정보를 제공하고 있습니다.

목차

제1장 개요

제2장 목차

제3장 그래프 리스트

제4장 표 리스트

제5장 보고서의 구조

제6장 서론과 시장의 특징

  • 일반적인 시장의 정의
  • 개요
  • 유도만능줄기세포(iPS 세포) 시장의 정의와 세분화
  • 시장 세분화 : 파생 세포 유형별
    • 혈액세포
    • 줄기세포
    • 섬유아세포
    • 각화세포
    • 양막
    • 기타
  • 시장 세분화 : 용도별
    • 학술 연구
    • Drug Discovery/독성 연구
    • 재생의료
    • 유전자 및 세포치료
  • 시장 세분화 : 최종사용자별
    • 병원
    • 연구기관

제7장 주요 시장 동향

  • 파킨슨병(PD) 치료에서의 다능성 줄기세포(PS세포) 사용
  • 전략적 협업과 파트너십
  • 유도만능줄기세포(iPS 세포) 유래 NK 세포 개발
  • 세포치료용 유도만능줄기세포(iPS 세포) 수요
  • 재생의료 연구개발에 대한 투자
  • 기술 이전과 임상 분석의 발전
  • 1형 당뇨병 치료에서의 다능성 줄기세포(PS세포) 사용

제8장 세계의 시장 규모와 성장

  • 시장 규모
  • 시장 성장 실적, 2016-2021년, 금액(100만 달러)
    • 시장 성장 촉진요인, 2016-2021년
    • 시장 성장 억제요인, 2016-2021년
  • 시장 성장 예측, 2021-2026년, 2031F, 금액(100만 달러)
    • 시장 성장 촉진요인, 2021-2026년
    • 시장 성장 억제요인, 2021-2026년

제9장 세계의 시장 세분화

  • 세계의 유도만능줄기세포(iPS 세포) 시장, 세분화 : 파생 세포 유형별, 실적/예측, 2016-2021년, 2026F, 2031F, 금액(100만 달러)
  • 세계의 유도만능줄기세포(iPS 세포) 시장, 세분화 : 최종사용자별, 실적/예측, 2016-2021년, 2026F, 2031F, 금액(100만 달러)
  • 세계의 유도만능줄기세포(iPS 세포) 시장, 세분화 : 용도별, 실적/예측, 2016-2021년, 2026F, 2031F, 금액(100만 달러)

제10장 세계 시장, 지역/국가별 분석

  • 세계의 유도만능줄기세포(iPS 세포) 시장, 지역별, 실적/예측, 2016-2021년, 2026F, 2031F, 금액(100만 달러)
  • 세계의 유도만능줄기세포(iPS 세포) 시장, 국가별, 실적/예측, 2016-2021년, 2026F, 2031F, 금액(100만 달러)

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 개요

제19장 기업 개요

  • FUJIFILM Holdings Corporation
  • Thermo Fisher Scientific, Inc
  • Takara Bio, Inc
  • Lonza Group AG
  • Astellas Pharma Inc

제20장 주요 인수합병(M&A)

제21장 기회 및 전략

제22장 결론 및 제안

제23장 부록

LSH 22.11.23

“Induced Pluripotent Stem Cell (IPSC) Global Market Opportunities And Strategies To 2031 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The induced pluripotent stem cell (iPSC) market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.

The report covers the following chapters:

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market.
  • Key Trends - Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
  • Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by derived cell type, by application, and by end-user in the market.
  • Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - Includes recommendations for induced pluripotent stem cell (IPSC) providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Derived Cell Type: Blood Cells; Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Others
  • 2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell & Gene Therapy
  • 3) By End-User: Hospitals; Research Laboratories
  • Companies Mentioned: FUJIFILM Holdings Corporation (FUJIFILM Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc.; Takara Bio, Inc.; Lonza Group AG; Astellas Pharma Inc.
  • Countries: Australia; China; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction and Market Characteristics

  • 6.1. General Market Definition
  • 6.2. Summary
  • 6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition and Segmentations
  • 6.4. Market Segmentation By Derived Cell Type
    • 6.4.1. Blood Cells
    • 6.4.2. Hepatocytes
    • 6.4.3. Fibroblasts
    • 6.4.4. Keratinocytes
    • 6.4.5. Amniotic
    • 6.4.6. Others
  • 6.5. Market Segmentation By Application
    • 6.5.1. Academic Research
    • 6.5.2. Drug Discovery And Toxicity Studies
    • 6.5.3. Regenerative Medicine
    • 6.5.4. Gene & Cell Therapy
  • 6.6. Market Segmentation By End-User
    • 6.6.1. Hospitals
    • 6.6.2. Research Laboratories

7. Major Market Trends

  • 7.1. Use of Pluripotent Stem Cells in treating Parkinson's Disease (PD)
  • 7.2. Strategic Collaborations And Partnerships
  • 7.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
  • 7.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy
  • 7.5. Investment In Regenerative Medicine Research And Development
  • 7.6. Advancements In Technology Transfer And Clinical Translation
  • 7.7. Use of Pluripotent Stem Cells in treating Type 1 Diabetes

8. Global Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
    • 8.2.1. Market Drivers 2016 - 2021
    • 8.2.2. Market Restraints 2016 - 2021
  • 8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
    • 8.3.1. Market Drivers 2021 - 2026
    • 8.3.2. Market Restraints 2021 - 2026

9. Global Market Segmentation

  • 9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

10. Global Market, Regional And Country Analysis

  • 10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

11. Asia-Pacific Market

  • 11.1. Summary
  • 11.2. Market Overview
    • 11.2.1. Region Information
    • 11.2.2. Market Information
    • 11.2.3. Background Information
    • 11.2.4. Government Initiatives
    • 11.2.5. Regulations
    • 11.2.6. Regulatory Bodies
    • 11.2.7. Major Associations
    • 11.2.8. Taxes Levied
    • 11.2.9. Corporate Tax Structure
    • 11.2.10. Investments
    • 11.2.11. Major Companies
  • 11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.7. Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 11.8. China Market
  • 11.9. Summary
  • 11.10. Market Overview
    • 11.10.1. Country Information
    • 11.10.2. Market Information
    • 11.10.3. Background Information
    • 11.10.4. Government Initiatives
    • 11.10.5. Regulations
    • 11.10.6. Regulatory Bodies
    • 11.10.7. Major Associations
    • 11.10.8. Taxes Levied
    • 11.10.9. Corporate Tax Structure
    • 11.10.10. Investments
    • 11.10.11. Major Companies
  • 11.11. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.15. India Market
  • 11.16. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.17. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.20. Japan Market
  • 11.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.23. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.25. Australia Market
  • 11.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.28. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.29. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.30. Indonesia Market
  • 11.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.32. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.33. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.34. South Korea Market
  • 11.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 11.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 11.37. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.38. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Western Europe Market

  • 12.1. Summary
  • 12.2. Market Overview
    • 12.2.1. Region Information
    • 12.2.2. Market Information
    • 12.2.3. Background Information
    • 12.2.4. Government Initiatives
    • 12.2.5. Regulations
    • 12.2.6. Regulatory bodies
    • 12.2.7. Major Associations
    • 12.2.8. Taxes Levied
    • 12.2.9. Corporate Tax Structure
    • 12.2.10. Investments
    • 12.2.11. Major Companies
  • 12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 12.8. UK Market
  • 12.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.13. Germany Market
  • 12.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 12.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.18. France Market
  • 12.19. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 12.20. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 12.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Eastern Europe Market

  • 13.1. Summary
  • 13.2. Market Overview
    • 13.2.1. Region Information
    • 13.2.2. Market Information
    • 13.2.3. Background Information
    • 13.2.4. Government Initiatives
    • 13.2.5. Regulations
    • 13.2.6. Regulatory Bodies
    • 13.2.7. Major Associations
    • 13.2.8. Taxes levied
    • 13.2.9. Corporate tax structure
    • 13.2.10. Investments
    • 13.2.11. Major Companies
  • 13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 13.8. Russia Market
  • 13.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. North America Market

  • 14.1. Summary
  • 14.2. Market Overview
    • 14.2.1. Region Information
    • 14.2.2. Market Information
    • 14.2.3. Background Information
    • 14.2.4. Government Initiatives
    • 14.2.5. Regulations
    • 14.2.6. Regulatory Bodies
    • 14.2.7. Major Associations
    • 14.2.8. Taxes levied
    • 14.2.9. Corporate tax structure
    • 14.2.10. Investments
    • 14.2.11. Major Companies
  • 14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.7. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 14.8. USA Market
  • 14.9. Summary
  • 14.10. Market Overview
    • 14.10.1. Country Information
    • 14.10.2. Market Information
    • 14.10.3. Background Information
    • 14.10.4. Government Initiatives
    • 14.10.5. Regulations
    • 14.10.6. Regulatory Bodies
    • 14.10.7. Associations
    • 14.10.8. Taxes Levied
    • 14.10.9. Corporate Tax Structure
    • 14.10.10. Investments
    • 14.10.11. Major Companies
  • 14.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. South America Market

  • 15.1. Summary
  • 15.2. Market Overview
    • 15.2.1. Region Information
    • 15.2.2. Market Information
    • 15.2.3. Background Information
    • 15.2.4. Government Initiatives
    • 15.2.5. Regulations
    • 15.2.6. Regulatory Bodies
    • 15.2.7. Associations
    • 15.2.8. Taxes Levied
    • 15.2.9. Corporate Tax Structure
    • 15.2.10. Investments
    • 15.2.11. Major Companies
  • 15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.7. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
  • 15.8. Brazil Market
  • 15.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. Middle East Market

  • 16.1. Summary
  • 16.2. Market Overview
    • 16.2.1. Region Information
    • 16.2.2. Market Information
    • 16.2.3. Background information
    • 16.2.4. Government Initiatives
    • 16.2.5. Regulations
    • 16.2.6. Regulatory bodies
    • 16.2.7. Major Associations
    • 16.2.8. Taxes levied
    • 16.2.9. Corporate tax structure
    • 16.2.10. Investments
    • 16.2.11. Major Companies
  • 16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. Africa Market

  • 17.1. Summary
  • 17.2. Market Overview
    • 17.2.1. Region Information
    • 17.2.2. Market Information
    • 17.2.3. Background Information
    • 17.2.4. Government Initiatives
    • 17.2.5. Regulations
    • 17.2.6. Regulatory bodies
    • 17.2.7. Major Associations
    • 17.2.8. Taxes levied
    • 17.2.9. Corporate tax structure
    • 17.2.10. Investments
    • 17.2.11. Major Companies
  • 17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Competitive Landscape And Company Profiles

19. Company Profiles

  • 19.1. FUJIFILM Holdings Corporation
    • 19.1.1. Company Overview
    • 19.1.2. Products And Services
    • 19.1.3. Business Strategy
    • 19.1.4. Financial Overview
  • 19.2. Thermo Fisher Scientific, Inc
    • 19.2.1. Company Overview
    • 19.2.2. Products And Services
    • 19.2.3. Business Strategy
    • 19.2.4. Financial Overview
  • 19.3. Takara Bio, Inc
    • 19.3.1. Company Overview
    • 19.3.2. Products And Services
    • 19.3.3. Business Strategy
    • 19.3.4. Financial Overview
  • 19.4. Lonza Group AG
    • 19.4.1. Company Overview
    • 19.4.2. Products And Services
    • 19.4.3. Business Strategy
    • 19.4.4. Financial Overview
  • 19.5. Astellas Pharma Inc
    • 19.5.1. Company Overview
    • 19.5.2. Products And Services
    • 19.5.3. Business Strategy
    • 19.5.4. Financial Overview

20. Key Mergers and Acquisitions

  • 20.1. Vertex Pharmaceuticals Acquired ViaCyte
  • 20.2. Medipost Acquired OmniaBio
  • 20.3. Catalent Acquired RheinCell Therapeutics
  • 20.4. Selvita Acquired Fidelta from Galapagos
  • 20.5. Bayer Acquired Asklepios BioPharmaceutical (AskBio)
  • 20.6. Boehringer Ingelheim Acquired Global Stem Cell Technology (GST)
  • 20.7. Vertex Pharmaceuticals Acquired Semma Therapeutics

21. Opportunities And Strategies

  • 21.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Countries Offering Most New Opportunities
  • 21.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Segments Offering Most New Opportunities
  • 21.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2026 - Growth Strategies
    • 21.3.1. Market Trend Based Strategies
    • 21.3.2. Competitor Strategies

22. Biotechnology Services Market, Conclusions And Recommendations

  • 22.1. Conclusions
  • 22.2. Recommendations
    • 22.2.1. Product
    • 22.2.2. Place
    • 22.2.3. Price
    • 22.2.4. Promotion
    • 22.2.5. People

23. Appendix

  • 23.1. Market Data Sources
  • 23.2. Research Methodology
  • 23.3. Currencies
  • 23.4. The Business Research Company
  • 23.5. Copyright and Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제